EUVIMEDEUVIMED entdecken
Crossref

Asymmetric (5 + 3) Annulation of Donor–Acceptor Cyclopropanes with Imidazolidines: Access to Saturated 1,4-Diazocanes

Liangliang Yang, Jieyin He, Haiyang Wang, Wendi Xu, Xue Zhang, Ming Lang, Jian Wang, Shiyong Peng

ACS Catalysis · 21.04.2023 · 13 (8) · 5752-5758

DOI: 10.1021/acscatal.3c01219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Catalysis, online erschienen am 13.04.2023. Verfasst von Liangliang Yang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, L., He, J., Wang, H., Xu, W., Zhang, X., Lang, M., Wang, J., & Peng, S. (2023). Asymmetric (5 + 3) Annulation of Donor–Acceptor Cyclopropanes with Imidazolidines: Access to Saturated 1,4-Diazocanes. ACS Catalysis, 13(8), 5752-5758. https://doi.org/10.1021/acscatal.3c01219

Vancouver

Yang L, He J, Wang H, Xu W, Zhang X, Lang M, et al. Asymmetric (5 + 3) Annulation of Donor–Acceptor Cyclopropanes with Imidazolidines: Access to Saturated 1,4-Diazocanes. ACS Catalysis. 2023;13(8):5752-5758. doi:10.1021/acscatal.3c01219

BibTeX
@article{Yang2023,
  author = {Yang, Liangliang and He, Jieyin and Wang, Haiyang and Xu, Wendi and Zhang, Xue and Lang, Ming and Wang, Jian and Peng, Shiyong},
  title = {Asymmetric (5 + 3) Annulation of Donor–Acceptor Cyclopropanes with Imidazolidines: Access to Saturated 1,4-Diazocanes},
  journal = {ACS Catalysis},
  year = {2023},
  volume = {13},
  number = {8},
  pages = {5752--5758},
  doi = {10.1021/acscatal.3c01219}
}
Kostenlos starten →